Hypertension, HFrEF + arrhythmias Flashcards
1
Q
Beta-1 antagonists for hypertension + what differentiates them
A
- atenolol (selective)
- propanolol (non-selective)
2
Q
Atenolol MOA/adverse effects
A
- blocks B-1 receptors in heart thus preventing effect of increase HR, contractility etc.
- block effects of B-1 receptors at different respiratory, CNS, CV etc.
- postural hypotension
3
Q
Propanolol MOA/adverse effects
A
- blocks B-1 + B-2 receptors at heart (more broad) to decrease HR + contractility + decrease hypertension
- block beta receptors in other places
cold extremities as vasodilation receptors blocked - postural hypotension
4
Q
Calcium channel blockers for hypertension and their classes
A
- dihydropyridines
- Nifedipine
- non-dihydropyridines
- verapimil
- dilitazem
5
Q
Nifedipine MOA/adverse effects
A
- blocks L type calcium channels in heart therefore blocking calcium current into cell thus decreasing Q, conduction, and increasing vasodilation of arteries
- dyspepsia
- bradycardia
6
Q
Verapimil MOA/adverse effects
A
- blocks L type calcium channels into heart therefore blocking calcium current into cell thus decreasing Q, conduction, and increasing vasodilation of arteries
- dyspepsia
- bradycardia
7
Q
Dilitazem MOA/adverse effects
A
- blocks L type calcium channels into heart therefore blocking calcium current into cell thus decreasing Q, conduction
8
Q
ACE inhibitors for hypertension
A
perindopril
9
Q
perindopril MOA/adverse effects
A
- binds to ACE enzyme + inhibits it therefore stopping conversion of angiotensin I to angiotensin II in RAAS cascade. Stops effectors so increases vasodilation + decreases symp. activity, ADH + aldosterone secretion
- hypotension, hyperkalemia
- increased bradykinin -> dry cough
10
Q
Alpha-1 antagonist for hypertension
A
Prazosin
11
Q
Prazosin MOA/adverse effects
A
- Inhibit a1 on vascular smooth muscle therefore causes vasodilation in veins + arteries -> decreases SVR + venous return to decrease BP
- postural hypotension
- lightheadedness
12
Q
AT1 receptor antagonists/angiotension receptor blockers for hypertension
A
Sartans eg. candesartan
13
Q
Candesartan MOA/adverse effects
A
- stop angiotensin II binding to AT1 receptor therefore causing vasodilation of blood vessels, decreased sympathetic activity, ADH + aldosterone secretion
14
Q
Replacement of ACE inhibitor in HFrEF
A
Salcubitril (with valsartan)
15
Q
Salcubitril + valsartan MOA/adverse effects
A
- inhibits neprilysin so causes vasodilation + increased GFR + bradykinin / decreases sympathetic tone + aldosterone release